Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Olaparib is used as maintenance treatment in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene, who have been treated with platinum-based cancer medicines. Your doctor will test for the presence of this gene.
Olaparib is also used to treat advanced ovarian cancer in patients who have received three or more previous lines of cancer treatment. It is used if the cancer cells have the germline BRCA mutations. Your doctor will use a special test to look for these mutations.
Olaparib is also used to treat ovarian cancer, fallopian tube cancer, or primary peritoneal cancer that has come back. It is used in patients who have received complete or partial treatment with platinum-based cancer medicines. It is also used to treat HER2-negative metastatic (cancer that has spread) breast cancer in patients who have been treated with other cancer medicines. Olaparib belongs to the group of medicines called antineoplastics (cancer medicines).
This medicine is available only with your doctor's prescription.
This product is available in the following dosage forms: